STME Stimcell Energetics Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1493712 · Fiscal year ends 05/31
Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-4.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-2,067.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets3,334.9%
Debt / equity—
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.39x
Accruals ratio-1,257.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2026*2026-05-31 | FY2025*2025-05-31 | FY2024*2024-05-31 | FY2023*2023-05-31 | FY2022*2022-05-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | $0 | $2,762 | $6,065 |
| Cost of revenue | — | — | — | — | $2,032 |
| Gross profit | — | — | $0 | $483 | $4,033 |
| R&D expense | — | — | — | $89,220 | $150,709 |
| SG&A expense | $382,560 | $213,452 | $116,353 | $275,534 | $334,223 |
| Interest expense | $69,348 | $38,256 | $61,651 | $47,384 | $25,686 |
| Net income | -$895,375 | -$566,293 | -$142,486 | -$495,042 | -$697,379 |
| EPS (basic) | -0.04 | -0.03 | -0.01 | -0.01 | -0.01 |
| EPS (diluted) | — | — | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $3,057 | $14,581 | $43,415 | $98,295 | $24,380 |
| Current assets | — | — | — | — | $41,344 |
| PP&E, net | — | — | — | — | $0 |
| Total assets | $81,454 | $21,222 | $46,122 | $103,270 | $41,344 |
| Total liabilities | $1.89M | $1.27M | $872,577 | $2.49M | $2.05M |
| Shareholders' equity | -$1.81M | -$1.25M | -$826,455 | -$2.39M | -$2.01M |
| Cash flow statement | |||||
| Operating cash flow | -$312,081 | -$141,600 | -$145,898 | -$272,209 | -$450,591 |
| Capital expenditure | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | -$450,591 |
| Investing cash flow | — | — | — | — | $0 |
| Financing cash flow | $300,582 | $112,858 | $91,033 | $346,364 | $453,971 |
| Depreciation & amortization | — | — | — | — | $1,145 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.